1 Study Coverage
    1.1 Pulmonary Surfactant Product Introduction
    1.2 Market by Type
        1.2.1 Global Pulmonary Surfactant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Synthetic Pulmonary Surfactants
        1.2.3 Animal Derived Surfactants
    1.3 Market by Application
        1.3.1 Global Pulmonary Surfactant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 laboratory
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pulmonary Surfactant Sales Estimates and Forecasts 2017-2028
    2.2 Global Pulmonary Surfactant Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pulmonary Surfactant Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pulmonary Surfactant Sales by Region
        2.4.1 Global Pulmonary Surfactant Sales by Region (2017-2022)
        2.4.2 Global Sales Pulmonary Surfactant by Region (2023-2028)
    2.5 Global Pulmonary Surfactant Revenue by Region
        2.5.1 Global Pulmonary Surfactant Revenue by Region (2017-2022)
        2.5.2 Global Pulmonary Surfactant Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pulmonary Surfactant Sales by Manufacturers
        3.1.1 Global Top Pulmonary Surfactant Manufacturers by Sales (2017-2022)
        3.1.2 Global Pulmonary Surfactant Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Surfactant in 2021
    3.2 Global Pulmonary Surfactant Revenue by Manufacturers
        3.2.1 Global Pulmonary Surfactant Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pulmonary Surfactant Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Surfactant Revenue in 2021
    3.3 Global Pulmonary Surfactant Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pulmonary Surfactant Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pulmonary Surfactant Sales by Type
        4.1.1 Global Pulmonary Surfactant Historical Sales by Type (2017-2022)
        4.1.2 Global Pulmonary Surfactant Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    4.2 Global Pulmonary Surfactant Revenue by Type
        4.2.1 Global Pulmonary Surfactant Historical Revenue by Type (2017-2022)
        4.2.2 Global Pulmonary Surfactant Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    4.3 Global Pulmonary Surfactant Price by Type
        4.3.1 Global Pulmonary Surfactant Price by Type (2017-2022)
        4.3.2 Global Pulmonary Surfactant Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pulmonary Surfactant Sales by Application
        5.1.1 Global Pulmonary Surfactant Historical Sales by Application (2017-2022)
        5.1.2 Global Pulmonary Surfactant Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    5.2 Global Pulmonary Surfactant Revenue by Application
        5.2.1 Global Pulmonary Surfactant Historical Revenue by Application (2017-2022)
        5.2.2 Global Pulmonary Surfactant Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    5.3 Global Pulmonary Surfactant Price by Application
        5.3.1 Global Pulmonary Surfactant Price by Application (2017-2022)
        5.3.2 Global Pulmonary Surfactant Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pulmonary Surfactant Market Size by Type
        6.1.1 North America Pulmonary Surfactant Sales by Type (2017-2028)
        6.1.2 North America Pulmonary Surfactant Revenue by Type (2017-2028)
    6.2 North America Pulmonary Surfactant Market Size by Application
        6.2.1 North America Pulmonary Surfactant Sales by Application (2017-2028)
        6.2.2 North America Pulmonary Surfactant Revenue by Application (2017-2028)
    6.3 North America Pulmonary Surfactant Market Size by Country
        6.3.1 North America Pulmonary Surfactant Sales by Country (2017-2028)
        6.3.2 North America Pulmonary Surfactant Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pulmonary Surfactant Market Size by Type
        7.1.1 Europe Pulmonary Surfactant Sales by Type (2017-2028)
        7.1.2 Europe Pulmonary Surfactant Revenue by Type (2017-2028)
    7.2 Europe Pulmonary Surfactant Market Size by Application
        7.2.1 Europe Pulmonary Surfactant Sales by Application (2017-2028)
        7.2.2 Europe Pulmonary Surfactant Revenue by Application (2017-2028)
    7.3 Europe Pulmonary Surfactant Market Size by Country
        7.3.1 Europe Pulmonary Surfactant Sales by Country (2017-2028)
        7.3.2 Europe Pulmonary Surfactant Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pulmonary Surfactant Market Size by Type
        8.1.1 Asia Pacific Pulmonary Surfactant Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pulmonary Surfactant Revenue by Type (2017-2028)
    8.2 Asia Pacific Pulmonary Surfactant Market Size by Application
        8.2.1 Asia Pacific Pulmonary Surfactant Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pulmonary Surfactant Revenue by Application (2017-2028)
    8.3 Asia Pacific Pulmonary Surfactant Market Size by Region
        8.3.1 Asia Pacific Pulmonary Surfactant Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pulmonary Surfactant Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Pulmonary Surfactant Market Size by Type
        9.1.1 Latin America Pulmonary Surfactant Sales by Type (2017-2028)
        9.1.2 Latin America Pulmonary Surfactant Revenue by Type (2017-2028)
    9.2 Latin America Pulmonary Surfactant Market Size by Application
        9.2.1 Latin America Pulmonary Surfactant Sales by Application (2017-2028)
        9.2.2 Latin America Pulmonary Surfactant Revenue by Application (2017-2028)
    9.3 Latin America Pulmonary Surfactant Market Size by Country
        9.3.1 Latin America Pulmonary Surfactant Sales by Country (2017-2028)
        9.3.2 Latin America Pulmonary Surfactant Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pulmonary Surfactant Market Size by Type
        10.1.1 Middle East and Africa Pulmonary Surfactant Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pulmonary Surfactant Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pulmonary Surfactant Market Size by Application
        10.2.1 Middle East and Africa Pulmonary Surfactant Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pulmonary Surfactant Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pulmonary Surfactant Market Size by Country
        10.3.1 Middle East and Africa Pulmonary Surfactant Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pulmonary Surfactant Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Corporation Information
        11.1.2 Boehringer Ingelheim Overview
        11.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Boehringer Ingelheim Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Boehringer Ingelheim Recent Developments
    11.2 AbbVie
        11.2.1 AbbVie Corporation Information
        11.2.2 AbbVie Overview
        11.2.3 AbbVie Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AbbVie Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AbbVie Recent Developments
    11.3 Lyomark Pharma
        11.3.1 Lyomark Pharma Corporation Information
        11.3.2 Lyomark Pharma Overview
        11.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Lyomark Pharma Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Lyomark Pharma Recent Developments
    11.4 Tekzima (Noargen)
        11.4.1 Tekzima (Noargen) Corporation Information
        11.4.2 Tekzima (Noargen) Overview
        11.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Tekzima (Noargen) Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Tekzima (Noargen) Recent Developments
    11.5 ONY Biotech
        11.5.1 ONY Biotech Corporation Information
        11.5.2 ONY Biotech Overview
        11.5.3 ONY Biotech Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 ONY Biotech Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 ONY Biotech Recent Developments
    11.6 Abbott
        11.6.1 Abbott Corporation Information
        11.6.2 Abbott Overview
        11.6.3 Abbott Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Abbott Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Abbott Recent Developments
    11.7 Aviva Systems Biology
        11.7.1 Aviva Systems Biology Corporation Information
        11.7.2 Aviva Systems Biology Overview
        11.7.3 Aviva Systems Biology Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Aviva Systems Biology Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Aviva Systems Biology Recent Developments
    11.8 LSBio
        11.8.1 LSBio Corporation Information
        11.8.2 LSBio Overview
        11.8.3 LSBio Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 LSBio Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 LSBio Recent Developments
    11.9 Biomatik
        11.9.1 Biomatik Corporation Information
        11.9.2 Biomatik Overview
        11.9.3 Biomatik Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Biomatik Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Biomatik Recent Developments
    11.10 Biorbyt
        11.10.1 Biorbyt Corporation Information
        11.10.2 Biorbyt Overview
        11.10.3 Biorbyt Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Biorbyt Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Biorbyt Recent Developments
    11.11 Reddot Biotech
        11.11.1 Reddot Biotech Corporation Information
        11.11.2 Reddot Biotech Overview
        11.11.3 Reddot Biotech Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Reddot Biotech Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Reddot Biotech Recent Developments
    11.12 XpressBio
        11.12.1 XpressBio Corporation Information
        11.12.2 XpressBio Overview
        11.12.3 XpressBio Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 XpressBio Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 XpressBio Recent Developments
    11.13 Creative Diagnostics
        11.13.1 Creative Diagnostics Corporation Information
        11.13.2 Creative Diagnostics Overview
        11.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Creative Diagnostics Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Creative Diagnostics Recent Developments
    11.14 Nanjing Norris Pharm Technology
        11.14.1 Nanjing Norris Pharm Technology Corporation Information
        11.14.2 Nanjing Norris Pharm Technology Overview
        11.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Nanjing Norris Pharm Technology Recent Developments
    11.15 Windtree Therapeutics
        11.15.1 Windtree Therapeutics Corporation Information
        11.15.2 Windtree Therapeutics Overview
        11.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Windtree Therapeutics Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Windtree Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pulmonary Surfactant Industry Chain Analysis
    12.2 Pulmonary Surfactant Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pulmonary Surfactant Production Mode & Process
    12.4 Pulmonary Surfactant Sales and Marketing
        12.4.1 Pulmonary Surfactant Sales Channels
        12.4.2 Pulmonary Surfactant Distributors
    12.5 Pulmonary Surfactant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pulmonary Surfactant Industry Trends
    13.2 Pulmonary Surfactant Market Drivers
    13.3 Pulmonary Surfactant Market Challenges
    13.4 Pulmonary Surfactant Market Restraints
14 Key Findings in The Global Pulmonary Surfactant Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Pulmonary Surfactant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Synthetic Pulmonary Surfactants
    Table 3. Major Manufacturers of Animal Derived Surfactants
    Table 4. Global Pulmonary Surfactant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Pulmonary Surfactant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Pulmonary Surfactant Sales by Region (2017-2022) & (K Units)
    Table 7. Global Pulmonary Surfactant Sales Market Share by Region (2017-2022)
    Table 8. Global Pulmonary Surfactant Sales by Region (2023-2028) & (K Units)
    Table 9. Global Pulmonary Surfactant Sales Market Share by Region (2023-2028)
    Table 10. Global Pulmonary Surfactant Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Pulmonary Surfactant Revenue Market Share by Region (2017-2022)
    Table 12. Global Pulmonary Surfactant Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Pulmonary Surfactant Revenue Market Share by Region (2023-2028)
    Table 14. Global Pulmonary Surfactant Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Pulmonary Surfactant Sales Share by Manufacturers (2017-2022)
    Table 16. Global Pulmonary Surfactant Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Pulmonary Surfactant Revenue Share by Manufacturers (2017-2022)
    Table 18. Pulmonary Surfactant Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Pulmonary Surfactant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Pulmonary Surfactant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Surfactant as of 2021)
    Table 21. Pulmonary Surfactant Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Pulmonary Surfactant Product Offered
    Table 23. Date of Manufacturers Enter into Pulmonary Surfactant Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pulmonary Surfactant Sales by Type (2017-2022) & (K Units)
    Table 26. Global Pulmonary Surfactant Sales by Type (2023-2028) & (K Units)
    Table 27. Global Pulmonary Surfactant Sales Share by Type (2017-2022)
    Table 28. Global Pulmonary Surfactant Sales Share by Type (2023-2028)
    Table 29. Global Pulmonary Surfactant Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Pulmonary Surfactant Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Pulmonary Surfactant Revenue Share by Type (2017-2022)
    Table 32. Global Pulmonary Surfactant Revenue Share by Type (2023-2028)
    Table 33. Pulmonary Surfactant Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Pulmonary Surfactant Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Pulmonary Surfactant Sales by Application (2017-2022) & (K Units)
    Table 36. Global Pulmonary Surfactant Sales by Application (2023-2028) & (K Units)
    Table 37. Global Pulmonary Surfactant Sales Share by Application (2017-2022)
    Table 38. Global Pulmonary Surfactant Sales Share by Application (2023-2028)
    Table 39. Global Pulmonary Surfactant Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Pulmonary Surfactant Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Pulmonary Surfactant Revenue Share by Application (2017-2022)
    Table 42. Global Pulmonary Surfactant Revenue Share by Application (2023-2028)
    Table 43. Pulmonary Surfactant Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Pulmonary Surfactant Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Pulmonary Surfactant Sales by Type (2017-2022) & (K Units)
    Table 46. North America Pulmonary Surfactant Sales by Type (2023-2028) & (K Units)
    Table 47. North America Pulmonary Surfactant Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Pulmonary Surfactant Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Pulmonary Surfactant Sales by Application (2017-2022) & (K Units)
    Table 50. North America Pulmonary Surfactant Sales by Application (2023-2028) & (K Units)
    Table 51. North America Pulmonary Surfactant Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Pulmonary Surfactant Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Pulmonary Surfactant Sales by Country (2017-2022) & (K Units)
    Table 54. North America Pulmonary Surfactant Sales by Country (2023-2028) & (K Units)
    Table 55. North America Pulmonary Surfactant Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Pulmonary Surfactant Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Pulmonary Surfactant Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Pulmonary Surfactant Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Pulmonary Surfactant Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Pulmonary Surfactant Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Pulmonary Surfactant Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Pulmonary Surfactant Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Pulmonary Surfactant Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Pulmonary Surfactant Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Pulmonary Surfactant Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Pulmonary Surfactant Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Pulmonary Surfactant Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Pulmonary Surfactant Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Pulmonary Surfactant Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Pulmonary Surfactant Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Pulmonary Surfactant Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Pulmonary Surfactant Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Pulmonary Surfactant Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Pulmonary Surfactant Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Pulmonary Surfactant Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Pulmonary Surfactant Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Pulmonary Surfactant Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Pulmonary Surfactant Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Pulmonary Surfactant Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Pulmonary Surfactant Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Pulmonary Surfactant Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Pulmonary Surfactant Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Pulmonary Surfactant Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Pulmonary Surfactant Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Pulmonary Surfactant Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Pulmonary Surfactant Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Pulmonary Surfactant Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Pulmonary Surfactant Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Pulmonary Surfactant Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Pulmonary Surfactant Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Pulmonary Surfactant Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Pulmonary Surfactant Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Pulmonary Surfactant Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Pulmonary Surfactant Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Pulmonary Surfactant Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Pulmonary Surfactant Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Pulmonary Surfactant Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Pulmonary Surfactant Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Pulmonary Surfactant Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Pulmonary Surfactant Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Pulmonary Surfactant Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Pulmonary Surfactant Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Pulmonary Surfactant Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Pulmonary Surfactant Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Boehringer Ingelheim Corporation Information
    Table 106. Boehringer Ingelheim Description and Major Businesses
    Table 107. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Boehringer Ingelheim Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Boehringer Ingelheim Recent Developments
    Table 110. AbbVie Corporation Information
    Table 111. AbbVie Description and Major Businesses
    Table 112. AbbVie Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. AbbVie Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. AbbVie Recent Developments
    Table 115. Lyomark Pharma Corporation Information
    Table 116. Lyomark Pharma Description and Major Businesses
    Table 117. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Lyomark Pharma Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Lyomark Pharma Recent Developments
    Table 120. Tekzima (Noargen) Corporation Information
    Table 121. Tekzima (Noargen) Description and Major Businesses
    Table 122. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Tekzima (Noargen) Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Tekzima (Noargen) Recent Developments
    Table 125. ONY Biotech Corporation Information
    Table 126. ONY Biotech Description and Major Businesses
    Table 127. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. ONY Biotech Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. ONY Biotech Recent Developments
    Table 130. Abbott Corporation Information
    Table 131. Abbott Description and Major Businesses
    Table 132. Abbott Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Abbott Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Abbott Recent Developments
    Table 135. Aviva Systems Biology Corporation Information
    Table 136. Aviva Systems Biology Description and Major Businesses
    Table 137. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Aviva Systems Biology Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Aviva Systems Biology Recent Developments
    Table 140. LSBio Corporation Information
    Table 141. LSBio Description and Major Businesses
    Table 142. LSBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. LSBio Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. LSBio Recent Developments
    Table 145. Biomatik Corporation Information
    Table 146. Biomatik Description and Major Businesses
    Table 147. Biomatik Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Biomatik Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Biomatik Recent Developments
    Table 150. Biorbyt Corporation Information
    Table 151. Biorbyt Description and Major Businesses
    Table 152. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Biorbyt Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Biorbyt Recent Developments
    Table 155. Reddot Biotech Corporation Information
    Table 156. Reddot Biotech Description and Major Businesses
    Table 157. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Reddot Biotech Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Reddot Biotech Recent Developments
    Table 160. XpressBio Corporation Information
    Table 161. XpressBio Description and Major Businesses
    Table 162. XpressBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. XpressBio Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. XpressBio Recent Developments
    Table 165. Creative Diagnostics Corporation Information
    Table 166. Creative Diagnostics Description and Major Businesses
    Table 167. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 168. Creative Diagnostics Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Creative Diagnostics Recent Developments
    Table 170. Nanjing Norris Pharm Technology Corporation Information
    Table 171. Nanjing Norris Pharm Technology Description and Major Businesses
    Table 172. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 173. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Nanjing Norris Pharm Technology Recent Developments
    Table 175. Windtree Therapeutics Corporation Information
    Table 176. Windtree Therapeutics Description and Major Businesses
    Table 177. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 178. Windtree Therapeutics Pulmonary Surfactant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Windtree Therapeutics Recent Developments
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Pulmonary Surfactant Distributors List
    Table 183. Pulmonary Surfactant Customers List
    Table 184. Pulmonary Surfactant Market Trends
    Table 185. Pulmonary Surfactant Market Drivers
    Table 186. Pulmonary Surfactant Market Challenges
    Table 187. Pulmonary Surfactant Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pulmonary Surfactant Product Picture
    Figure 3. Global Pulmonary Surfactant Market Share by Type in 2021 & 2028
    Figure 3. Synthetic Pulmonary Surfactants Product Picture
    Figure 4. Animal Derived Surfactants Product Picture
    Figure 5. Global Pulmonary Surfactant Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. laboratory
    Figure 8. Others
    Figure 9. Pulmonary Surfactant Report Years Considered
    Figure 10. Global Pulmonary Surfactant Sales 2017-2028 (K Units)
    Figure 11. Global Pulmonary Surfactant Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Pulmonary Surfactant Revenue 2017-2028 (US$ Million)
    Figure 13. Global Pulmonary Surfactant Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Pulmonary Surfactant Sales Market Share by Region (2017-2022)
    Figure 15. Global Pulmonary Surfactant Sales Market Share by Region (2023-2028)
    Figure 16. North America Pulmonary Surfactant Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Pulmonary Surfactant Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Pulmonary Surfactant Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Pulmonary Surfactant Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Pulmonary Surfactant Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Pulmonary Surfactant Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Pulmonary Surfactant Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Pulmonary Surfactant Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Pulmonary Surfactant Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Pulmonary Surfactant Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Pulmonary Surfactant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Pulmonary Surfactant in the World: Market Share by Pulmonary Surfactant Revenue in 2021
    Figure 28. Global Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    Figure 30. Global Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    Figure 31. Global Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    Figure 32. Global Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    Figure 33. North America Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    Figure 34. North America Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    Figure 35. North America Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    Figure 36. North America Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    Figure 37. North America Pulmonary Surfactant Sales Share by Country (2017-2028)
    Figure 38. North America Pulmonary Surfactant Revenue Share by Country (2017-2028)
    Figure 39. U.S. Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    Figure 42. Europe Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    Figure 44. Europe Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Pulmonary Surfactant Sales Share by Country (2017-2028)
    Figure 46. Europe Pulmonary Surfactant Revenue Share by Country (2017-2028)
    Figure 47. Germany Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 48. France Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Pulmonary Surfactant Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Pulmonary Surfactant Revenue Share by Region (2017-2028)
    Figure 58. China Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 61. India Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Pulmonary Surfactant Sales Share by Country (2017-2028)
    Figure 73. Latin America Pulmonary Surfactant Revenue Share by Country (2017-2028)
    Figure 74. Mexico Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Pulmonary Surfactant Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Pulmonary Surfactant Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Pulmonary Surfactant Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Pulmonary Surfactant Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Pulmonary Surfactant Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Pulmonary Surfactant Revenue Share by Country (2017-2028)
    Figure 83. Turkey Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Pulmonary Surfactant Revenue (2017-2028) & (US$ Million)
    Figure 86. Pulmonary Surfactant Value Chain
    Figure 87. Pulmonary Surfactant Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed